Factors Associated with Retention in HIV Care at Sediba Hope Medical Centre by Ramdas, N et al.
Page 1 of 6 Original Research
http://www.sajhivmed.org.za doi:10.4102/sajhivmed.v16i1.347
Background: Lost to follow-up (LTFU) is a major challenge that hinders the success of 
antiretroviral treatment (ART).
Objective: To identify factors conducted to a low LTFU rate.
Methods: We conducted a two-part descriptive and quantitative study. Part 1 comprised 
interviews with clinic staff to determine their perspectives on LTFU and to establish the 
clinic’s follow-up procedures for patients on ART. Part 2 of the study was a retrospective 
review of clinic and patient records. LTFU patients were identified and those with contact 
details were contacted for telephonic interview to determine if they were still on ART and/or 
their reasons for becoming LTFU.
Results: A low LTFU rate (7.9%; N = 683) was identified. Work-related stress, and lack of 
transport and funds were reported reasons for LTFU. Monthly visits, non-adherent defaulters 
and LTFU patients were tracked by an electronic system (SOZO). Factors contributing to high 
rates of retention in care were: location of the clinic in the inner city, thus in close proximity 
to patients’ homes or work; clinic operating on Saturdays, which was convenient for patients 
who could not attend during the week; an appointment/booking system that was in place and 
strictly adhered to; a reminder SMS being sent out the day before an appointment; individual 
counselling sessions at each visit and referrals where necessary; and a stable staff complement 
and support group at the clinic.
Conclusion: Achieving a low LTFU rate is possible by having a patient-centred approach and 
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Adhering to antiretroviral treatment (ART) is a lifelong commitment that requires patients to 
diligently adhere to daily medication dosing schedules and make regular clinic visits for care.1 
ART has improved the lives of many people living with the human immunodeficiency virus 
(HIV), but many challenges still exist before ART programmes might achieve total success in 
terms of patient outcomes.1 Two of the major challenges and concerns for ART programmes 
are retention in care and patients who are lost to follow-up (LTFU).1 Several studies have been 
conducted on these problems, investigating various ways to improve retention in HIV care and 
patient outcomes.1,2,3,4
‘Lost to follow-up’ refers to the disappearance of a patient from the programme, for no reported 
reason.5 Definitions of when a patient is classified as LTFU vary widely across studies and 
countries.6 In a pooled analysis of 111 facilities, a threshold of 180 days since the last clinic visit 
was recommended as a standard definition for LTFU.7
In sub-Saharan African countries, rates of LTFU vary extensively. According to a systematic 
review of patient retention following ART initiation, it was evident that 1 year after initiation 
approximately 25% of patients were no longer in care, with LTFU figures escalating to 40% after 
2 years.8 Lower LTFU figures (3.3%; N = 2548) were reported from a retrospective cross-sectional 
study of a community-based ART cohort in Cape Town, South Africa, which used a computerised 
tracking tool to manage patients in care.9
Sediba Hope Medical Centre (SHMC) is a nongovernmental organisation (NGO) clinic, situated in 
the city centre of Tshwane in South Africa. It caters for patients working and living in and around 
the city of Tshwane. The centre was previously known as Fountain of Hope (FOH), which was 
a Foundation for Professional Development (FPD) clinic funded by the President’s Emergency 
Plan for AIDS Relief (PEPFAR) and the United States Agency for International Development 
(USAID). The clinic’s budget allowance provided for a patient database of only 500 patients. 
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The main purpose of the FOH Clinic was to provide ART for 
HIV-positive patients living and working in the inner city. 
In 2011, FPD joined in a project with Participate Empower 
and Navigate (PEN), a non-profit, non-denominational, 
faith-based organisation, and subsequently the FOH Clinic 
became the SHMC. Since the name change, it has operated 
as an ARV site for the PEPFAR- and USAID-funded patients 
on ART and as a primary healthcare (PHC) private practice 
for patients using medical aid or paying privately. The move 
from the FOH Clinic to the SHMC had some implications for 
patients as they had to adapt to a new site, new processes, 
new staff and additional travelling distances for some 
patients. Patients living near the FOH Clinic had to walk an 
average of 1.4 km further to the SHMC, which represents 
approximately 17 minutes.
LTFU had not been evaluated at this site previously. In the 
present study, we aimed to quantify LTFU at the SHMC, 
investigate the factors that contributed to patients on ART 
becoming LTFU, and identify factors that could contribute 
to low LTFU rates and be implemented to improve retention 
in care.
Methods
Patient population and data collection
We conducted a two-part descriptive and quantitative study 
at SHMC between August and November 2013. The first part 
of the study included an individual interview based on a 
structured questionnaire with each of the nine staff members. 
We aimed to determine staff members’ perspectives on the 
reasons for LTFU and to establish the procedures used at the 
clinic to monitor patients on ART and to identify and trace 
those who were LTFU.
The second part of the study was a retrospective review 
of clinic and patient records for the previous 4 years 
(2010–2013). The review included ‘hard copy’ patient files 
and an electronic patient management system, known as 
SOZO, which was developed by FPD in partnership with 
Infocare and John Snow International (JSI) in 2007. All 
patients on ART, who had become LTFU with no obvious 
reason for default, were identified. A patient record sheet 
was used to record LTFU patients’ details from their 
files and the SOZO system. Patients identified as LTFU, 
with contact details in their records, were contacted 
telephonically for a structured telephonic interview to 
investigate reasons for LTFU.
Data analysis
Data were analysed with SPSS V21.0 statistical software. 
The percentage of LTFU patients was calculated with a 
95% confidence interval. Patient demographics and clinical, 
treatment and social data were summarised descriptively. 
Associations between variables and differences in means 
were identified with Fisher’s exact test and independent 
samples t-test as appropriate. Statistical significance was set 
at p ≤ 0.05.
Ethical approval
Ethical clearance for the study was granted by the Medunsa 
Research Ethics Committee of the University of Limpopo. 
Permission to conduct the study at the SHMC was provided 
by FPD and the manager of SHMC. Written consent was 
obtained from staff members of SHMC and verbal consent 
from responding patients, prior to their participation in the 
interviews.
Results
SHMC is conveniently situated in the city centre; that is, 
close to home or work for most patients. The clinic operates 
on weekdays as well as Saturdays to accommodate patients 
who work or are unable to attend the clinic during the 
week. The previous FOH Clinic also hosted a support group 
with regular meetings every second Saturday, which were 
available to all patients from the time they started treatment.
Patient flow process and tracking of lost to 
follow-up patients
Interviews with staff members revealed that the clinic 
followed a structured patient flow process, according to 
which patients were seen by appointment only and according 
to bookings done on the SOZO system. According to the staff 
interviewed, patient waiting time was kept to a minimum, 
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FIGURE 1: Flow process of monitoring and tracking patients on antiretroviral 
treatment at Sediba Hope Medical Centre.
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as appointments were made according to a time schedule. 
The patient flow process and the tracking of LTFU patients at 
SHMC are illustrated in Figure 1.
Patients at SHMC are sent a reminder short message service 
(SMS) the day prior to their scheduled appointment. A 
booking list is printed daily to track patients as they attend. 
The service received is personalised and, should patients 
not attend their appointment, follow-up phone calls are 
made.
When a patient on ART is identified as LTFU, the social 
worker phones the patient weekly or at least bi-monthly 
for a period of 3 months, in an attempt to reschedule an 
appointment and get the patient back into care. All phone 
numbers on patient records are contacted in an attempt to 
trace them. After 3 months of no success in tracing a patient, 
no further action is taken.
The staff complement at the previous FOH Clinic was stable 
for a period of 4 years and, consequently, patients interacted 
with the same healthcare worker at each visit. For this reason, 
patients felt comfortable and built good relationships with 
the staff.
Extent of lost to follow-up
Of the total number of 683 patient records reviewed, 54 
(7.9%; 95% confidence interval [CI], 6.1%–10.2%) patients 
were identified as LTFU (Figure 2). Only 17 of the 54 patients 
had contact details in their records and were contacted for 
a telephonic interview. Sociodemographic characteristics of 
the 54 patients who were LTFU are summarised in Table 1.
Disclosure of HIV status
According to the patient records, most patients (90.7%; 
N = 54) had disclosed their HIV status. Women preferred 
to disclose to a relative (82.1%; n = 28) rather than a partner 
(28.6%; n = 28) whilst men disclosed mainly to relatives 
(46.1%; n = 26) and their partners (42.3%; n = 26). Three male 
patients did not disclose their status to anybody.
Travelling distance to the clinic
Travelling distance to the clinic was known for 16 of the 17 
LTFU patients who were contacted for an interview. Nine of 
them (56.3%) lived less than 1 km away from the clinic, and 
so required minimal travelling; 3 (18.8%) lived between 1 km 
and 5 km from the clinic; and 4 (25.0%) lived more than 10 km 
from the clinic.
Clinical profile of lost to follow-up patients: CD4+ cell 
count and viral load
Table 2 shows the gender distribution of LTFU patients, 
for whom CD4+ cell count test results were available 
within 6 months of their final clinic visit, prior to becoming 
LTFU.
The median CD4+ count for patients (n = 35) who had a 
test done within 6 months of their last clinic visit prior to 
1
1. Active on ART (92.1%)
2. LTFU with contact details (2.5%) 
3. LTFU without contact details (5.4%)
2 3
N = 683.
LTFU, lost to follow-up; ART, antiretroviral treatment.
FIGURE 2: Overall proportion of patients lost to follow-up at Sediba Hope 
Medical Centre.
TABLE 1: Sociodemographic characteristics of lost to follow-up patients.
Sociodemographics Characteristics n %
Gender Male 26 48.1
Female 28 51.9




Educational level No education 2 7.1
Primary education completed 1 3.6
Secondary education not completed 9 32.1
Secondary education completed 11 39.3
Tertiary or vocational education 5 17.9





TABLE 2: Distribution of patients according to CD4+ cell count results, based on testing done within 6 months of the patient’s final clinic visit prior to becoming lost to 
follow-up.
CD4+ count (cells/µL) Male† %* Female‡ %* Total§ %
< 100 2 5.7 2 5.7 4 11.4
100–350 15 42.9 5 14.3 20 57.2
> 350 1 2.9 10 28.6 11 31.4
Range 11–1382 69–656 11–1382
Median 255.0 431.0 289.0
IQR 173.25–299.0 253.0–471.5 186–438
Mean ± s.d. 287.8 ± 287.6 371.9 ± 167.0 328.6 ± 237.3
Mean difference (95% CI) 84.1 (-247.1–78.9)**
†, n = 18; ‡, n = 17; §, N = 35.
*, p = 0.001, Fisher’s exact test; **, p = 0.302, independent samples t-test.
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becoming LTFU was 289.0 cells/µL (interquartile range 
[IQR] 186–438), with a CD4+ count below 350 cells/µL for 
the majority (68.6%) of them. Categorisation of CD4+ count 
results available within 6 months of the final clinic visit 
prior to becoming LTFU showed a statistically significant 
association with gender (p = 0.001; Fisher’s exact test). 
Being female was associated with the probability of a CD4+ 
count > 350 cells/µL, and being male was associated with a 
probability of a lower CD4+ count (100 cells/µL – 350 cells/µL) 
at the time of being LTFU.
A detectable viral load (VL) within 6 months of their final 
visit to the clinic was evident in 44.1% (n = 35) of patients, 
with more of the men (58.8%; n = 17) than the women (29.4%; 
n = 17) having a detectable VL. The association between 
gender and detectable VL was, however, not significant 
(p = 0.472; Fisher’s exact test).
Antiretroviral treatment and adherence
At the time of their final visit, just more than half of LTFU 
patients (57.4%; n = 54) were on the current first-line regimen, 
comprising tenofovir (TDF), lamivudine (3TC) and efavirenz 
(EFV). Thirteen per cent of the LTFU patients were still on the 
previous Regimen 1A (stavudine [d4T], 3TC, EFV) and 11.1% on 
the previous Regimen 1B (d4T, 3TC, nevirapine [NVP]). Only 
13% of LTFU patients were on the second-line regimen (TDF, 
3TC or emtricitabine [FTC] and lopinavir/ritonavir [LPV/r]).
Adherence to ART at the SHMC was monitored at each visit 
by means of pill counts, conducted by the social worker or 
counsellor and recorded as descriptive notes in the patient 
files and on the SOZO system. Table 3 shows the adherence 
patterns for patient visits over the period of 3 months prior 
to becoming LTFU.
Reasons for lost to follow-up
Staff members’ perceptions of the reasons for LTFU are 
summarised in Table 4.
Based on the contact details available in the files of patients 
identified as LTFU, only 17 patients could be contacted 
successfully for a telephonic interview. One patient was 
identified to have demised while on ART. Another patient 
had relocated to Europe, and it could not be determined 
whether he was still on ART or not.
Nine patients were confirmed to be still active on ART 
at other sites, of whom one patient was actually LTFU at 
SHMC before initiation on ART. This patient subsequently 
commenced ART at another site, as he moved from one 
city to another. Three patients indicated that they were 
using delivery services to obtain their ARVs. Explanations 
from the remaining five patients who continued treatment 
at a different ART facility were related to proximity and 
travelling time. Two of these patients reported that the 
alternative facility was closer to home, and three reported it 
as being closer to their workplace.
Only six of the patients interviewed reported that they had 
discontinued ART altogether. All six patients provided 
transport costs as a reason for discontinuing treatment; 2 
of these patients also mentioned the side-effects of ARVs, 
whilst one patient was using traditional or herbal medication 
instead of ARVs.
Discussion
The LTFU rate at the SHMC (7.9%; N = 683) was evidently 
much lower in comparison to most sub-Saharan countries.1,9 
This reasonably low LTFU rate could be attributed to various 
processes at the centre, one being the follow-up of patients 
from an early stage after a missed appointment at the clinic. 
A previous study confirmed that early active follow-up of 
patients can improve retention on treatment and programme 
outcomes.9
The use of an electronic patient management system (SOZO) 
facilitated patient follow-up and engagement, thus improving 
the efficiency of the system immensely. Appointments were 
booked electronically according to a time schedule which, 
according to the staff, minimised patient waiting time. 
A large ART programme in Malawi also considered time-
specific appointments for each patient as an option to reduce 
waiting times.2 In addition, the SOZO system identified 
patients due for appointment, and a reminder SMS was 
sent to them the day beforehand. Similarly, low LTFU rates 
(3.3%) were identified elsewhere in South Africa where a 
computerised pharmacy tracking system (iDART) was used 
to trace patients who failed to collect their medication.9
TABLE 3: Adherence patterns over the period of 3 months prior to becoming lost to follow-up.
Adherence level Number (%) of patient visits
Third-last month† % Second-last month‡ % Month prior to LTFU§ % Total %
Excellent adherence 10 23.9 4 9.1 2 4.3 16 12.0
Adherent 27 64.3 34 77.3 30 63.8 91 68.4
Non-adherent 5 11.9 6 13.6 15 31.9 26 19.6
N = 133; †, n = 42; ‡, n = 44; §, n = 47.
TABLE 4: Reported reasons for lost to follow-up, according to staff perceptions.
Reasons for lost to follow-up Number
Work-related stress (e.g. cannot take leave to attend clinic) 7
Lack of transport 5
Only one month’s supply of ART (opposed to 3 months’ supply 
issued previously)
5
Strenuous/tedious to attend clinic every month 2
Stigma/shame 1
Foreigners going back home 1
Patients moving to other provinces 1
Domestic abuse 1
N = 9.
Some participants provided more than one reason.
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Most (90.7%) of the LTFU patients disclosed their HIV status, 
which was a positive finding and attributed to the fact that 
disclosure is encouraged during counselling. Disclosure of 
HIV status to one’s spouse is known to be associated with 
good adherence.10
Women in our study had a higher CD4+ count at the time of 
being LTFU. This could be expected as previous studies from 
sub-Saharan Africa have shown that women usually have 
a higher CD4+ count at ART initiation and a better median 
CD4+ count increase from baseline across all time periods 
after ART initiation, than men.11
It is evident that an elevated VL may be a factor to consider 
for LTFU, which is supported by the findings from other 
studies which demonstrated that unsuppressed viral loads at 
any time point in treatment are predictive of loss.12
Good adherence rates were supported by consistent pill 
counts and counselling sessions, which happened at each 
clinic visit. Having a stable staff complement at the clinic 
meant that patients saw the same counsellor or social worker 
at every visit, which facilitated good relationships between 
staff and patients. The staff perceived the regular support 
group meetings as a contributing factor to adherence. 
Support groups are known to encourage adherence and 
improve retention in care.13
From our findings, it was apparent that work-related stress, 
lack of transportation, and lack of funds for travel and food 
were reported as contributing factors to LTFU at SHMC. 
Travelling distance was the main reported reason why 
patients changed facilities and opted for a clinic closer to home 
or to work, or preferred the convenience of ART delivery 
services to their home or work. High transport costs and 
patients having to travel long distances to get to ARV clinics 
were identified as problems in a study conducted at Themba 
Lethu Clinic, Helen Joseph Hospital, in Johannesburg, South 
Africa.3 Lack of transport and employment obstacles as 
reasons for LTFU are supported by a number of other studies 
conducted in South Africa and Mozambique.3,14,15
Lack of availability of contact details for all patients at SHMC 
made follow-up and tracing of LTFU patients difficult in 
our study. The majority of LTFU patients had incorrect 
information or no contact information at all. It is apparent 
that ART programmes should invest in obtaining accurate, 
complete and up-to-date contact details for patients to aid 
tracing. Availability of more updated contact information 
for all patients at SHMC may have resulted in an even lower 
number of LTFUs altogether.
Limitations
Our study was conducted at only one facility and the results 
can therefore not be generalised to other ART facilities in 
South Africa. Incomplete and incorrect patient records 
(manual and SOZO system) made it difficult to trace all 
LTFU patients and therefore negatively affected the number 
of LTFU patients interviewed. A limitation of the study itself 
was that the review did not include patients who remained in 
care. Consequently, comparisons between LTFU patients and 
those who remained in care were not possible. Furthermore, 
as a result of incomplete clinic records, information about the 
proportion of patients who did not become LTFU as a result of 
successful contact by social workers could not be determined.
Conclusion
From our study, it is evident that low LTFU rates and 
measures to prevent LTFU are possible. The flow through 
the clinic was efficient and patients in general were pleased 
with the services rendered at SHMC. Most patients had 
built good relationships with the staff, which made them 
feel comfortable and cared for. The complete functioning of 
SHMC took the form of a patient-centred approach and was 
much more than only having a computer system in place.
SHMC can be an example to similar ART sites with high LTFU 
rates. The SMS reminder service and tracking system may 
benefit other ART sites. Seeing patients on an appointment 
only basis proved to be beneficial. However, it might be 
difficult in facilities with larger numbers of patients.
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